Burden of illness of neovascular age-related macular degeneration in Canada

2004, Magnitude and causes of visual impairment, Fact sheet 282

Klein, 1992, The Beaver Dam Eye Study, Ophthalmology, 99, 933, 10.1016/S0161-6420(92)31871-8

Ambati, 2003, Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies, Surv Ophthalmol, 48, 257, 10.1016/S0039-6257(03)00030-4

Bonastre, 2003, The burden of age-related macular degeneration: results of a cohort study in two French referral centres, Pharmacoeconomics, 21, 181, 10.2165/00019053-200321030-00003

Hopley, 2003, Measurement of the economic impact of visual impairment from age-related macular degeneration in Australia, Clin Experiment Ophthalmol, 31, 522, 10.1046/j.1442-9071.2003.00715.x

Hart, 1999, A vision specific functional index for use in patients with age related macular degeneration, Br J Ophthalmol, 83, 1115, 10.1136/bjo.83.10.1115

Williams, 1998, The psychosocial impact of macular degeneration, Arch Ophthalmol, 116, 514, 10.1001/archopht.116.4.514

Chia, 2004, Impact of bilateral visual impairment on health-related quality of life: the Blue Mountains Eye Study, Invest OphthalmolVis Sci, 45, 71, 10.1167/iovs.03-0661

Brown, 2005, Age-related macular degeneration: economic burden and value-based medicine analysis, Can J Ophthalmol, 40, 277, 10.1016/S0008-4182(05)80070-5

Schmier, 2006, The burden of age-related macular degeneration, Pharmacoeconomics, 24, 319, 10.2165/00019053-200624040-00003

Sharma, 2004, Economic resources utilized in a cohort of patients with age-related macular degeneration (AMD), Value Health, 7, 260, 10.1016/S1098-3015(10)62188-2

Sharma, 2005, Drug pricing for a novel treatment for wet macular degeneration: using incremental cost-effectiveness ratios to ensure societal value, Can J Ophthalmol, 40, 369, 10.1016/S0008-4182(05)80079-1

Soubrane, 2007, Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study, Arch Ophthalmol, 125, 1249, 10.1001/archopht.125.9.1249

Mangione, 1998, Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ), Arch Ophthalmol, 116, 1496, 10.1001/archopht.116.11.1496

Mangione, 2001, Development of the 25-item National Eye Institute Visual Function Questionnaire, Arch Ophthalmol, 119, 1050, 10.1001/archopht.119.7.1050

Rabin, 2001, EQ-5D: a measure of health status from the EuroQol Group, Ann Med, 33, 337, 10.3109/07853890109002087

Zigmond, 1983, The hospital anxiety and depression scale, Acta Psychiatr Scand, 67, 361, 10.1111/j.1600-0447.1983.tb09716.x

2003

Miskala, 2003, Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization—SST Report No/ 1, Arch Ophthalmol, 121, 531, 10.1001/archopht.121.4.531

Espallargues, 2005, The impact of age-related macular degeneration on health status utility values, Invest Ophthalmol Vis Sci, 46, 4016, 10.1167/iovs.05-0072

Ivers, 2000, Visual impairment and risk of hip fracture, Am J Epidemiol, 152, 633, 10.1093/aje/152.7.633

Legood, 2002, Are we blind to injuries in the visually impaired? A review of the literature, Inj Prev, 8, 155, 10.1136/ip.8.2.155

Eichenbaum, 1999, The prevalence of eye disease in nursing home and non-nursing home geriatric populations, Arch Gerontol Geriatr, 28, 191, 10.1016/S0167-4943(99)00009-6